Status:
COMPLETED
Reactions to Disease Risk Information
Lead Sponsor:
National Human Genome Research Institute (NHGRI)
Conditions:
Cancer
Eligibility:
All Genders
25-40 years
Phase:
NA
Brief Summary
This study is part of an effort to learn about interactions between doctors and patients. The study will use virtual reality technology to examine how patients and doctors interact when they discuss d...
Detailed Description
This study will investigate interactions between doctors and patients regarding risks of common, complex diseases using virtual reality technology. Men and women between the ages of 25 and 40 who hav...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Self-reported ability to speak, read, and write in English.
- Self identifying as African-American or Black
- Having been born and raised in the U.S.
- Not having been diagnosed with any of the diseases used in the experiment.
- Being between 25 and 40 years of age.
- Having access to the Internet.
- Both men and women will be included in the study.
- EXCLUSION CRITERIA:
- Individuals below the age of 25 because they might not yet have completed their education and those above the age of 40 because they might have less familiarity with interactive technologies than younger individuals.
- Because the study will utilize virtual reality technology, individuals who are particularly susceptible to motion sickness will be excluded.
- All individuals with epilepsy, low vision, hearing problems, and vestibular disorders (e.g., vertigo) will be excluded from the study for safety reasons.
- We will re-screen for safety exclusion criteria when participants arrive to participate in the in-person portion of the study.
Exclusion
Key Trial Info
Start Date :
June 16 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2010
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT00774254
Start Date
June 16 2009
End Date
September 30 2010
Last Update
October 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892